Market Pulse: Tech’s green lights, courtesy of Nvidia, gave the Dow a rocket boost yesterday while the S&P and Nasdaq crept lower.
Key Movers: Goldman Sachs crushed trading estimates, JPMorgan Chase extended its beat streak to six quarters, and Johnson & Johnson beat expectations and raised its full-year outlook.
Macro & Politics: Bloomberg buzzed that Trump may replace Fed Chair Powell, stirring fresh uncertainty over central bank independence.
What’s Next: Keep an eye on upcoming FDA approvals and merger catalysts to see if this momentum holds.
📈 Breaking Financial News
[Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Ultomiris Drug Market size & share revenue was valued at approximately USD 4.16 Billion in 2024 and is expected to reach USD 5.4…
JPMorgan Chase Set To Explore Stablecoins, Says CEO Jamie Dimon
In a recent earnings call, Jamie Dimon, CEO of JPMorgan Chase, expressed skepticism about the appeal of stablecoins but acknowledged that his bank cannot afford to ignore this evolving financial technology. Dimon Embraces Stablecoins Despite Skepticism Last …
Chainlink price forecast amid US asset tokenization push with Blockchain Association partnership
Chainlink (LINK) eyes a breakout with $17.5 as a key resistance level. Chainlink partners to promote tokenisation across US states. Technicals and sentiment support a bullish price outlook. Chainlink (LINK) is once again making headlines, this time for a pivo…
Why Jamie Dimon thinks asset prices are ‘elevated': Opening Bid top takeaways
Earnings season is officially underway.
AI Appreciation Day 2025: Enterprise Leaders Are Scaling AI Beyond the Hype to Drive Real Business Value
As we celebrate AI Appreciation Day 2025, the conversation has shifted dramatically from “What can AI do?” to “How do we implement AI and drive business value?”
Claim Your Starlink Pre-IPO Prospectus
This is a critical and time-sensitive message. It's regarding Starlink, which is expected to be the largest IPO in history – set to take place in as little as a few weeks. And for the first time ever, we've found a way for you to profit BEFORE the IPO happens. One of the world's top venture capitalists and Silicon Valley insiders has just released all of the details… including a prospectus… in this short message. Click here now to discover how to take action BEFORE the IPO.
🔍 Market Analysis & Insights
Nisa Investment Advisors LLC Trims Stock Position in Teradyne, Inc. (NASDAQ:TER)
Nisa Investment Advisors LLC trimmed its position in Teradyne, Inc. (NASDAQ:TER – Free Report) by 67.7% during the first quarter, HoldingsChannel.com reports. The firm owned 6,383 shares of the company’s stock after selling 13,384 shares during the quarter. N…
Up to 7.5% Yield and a “Strong Buy” Rating? These 3 Dividend Stocks Check Every Box.
These three dividend stocks have the highest dividend yield among large-cap companies today.
Biocon shares surge 3% as subsidiary obtains USFDA approval for diabetes drug
Biocon share price jumped after its subsidiary Biocon Biologics received USFDA approval for Kirsty, a rapid-acting insulin biosimilar. This makes it the first interchangeable version of NovoLog in the U.S., expanding Biocon’s insulin portfolio amid a growing …
D-Wave Quantum: Can QBTS Stock Deliver Another 1,000% Gain?
QBTS has witnessed immense growth, skyrocketing over 1,000% in the past twelve months due to increasing enthusiasm for quantum computing.
Sonic activity surges 89% – Will price catch up or stall again?
Despite bullish on-chain growth, Sonic faces strong sell pressure and weakening market confidence.
I Never Thought My Private Messages Would See The Light Of Day
Ever since Nov. 4th, there's been a huge surge in one specific type of trading opportunity. Go here to see more of my private messages… and the 3-part plan my friends and I are using to go after incredible potential gains in 2025: Leaked Private Messages Reveal Tim's 2025 Trade Plan?
💰 Investment Opportunities
Trump likely to fire Fed Chair Powell soon, Bloomberg reports
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
PaladinMining Launches Robinhood Wallet Integration, Unlocking Daily Returns Up to $7,777
LONDON, UK,, July 16, 2025 (GLOBE NEWSWIRE) — PaladinMining, a global leader in cloud mining solutions, has announced a major update to its platform, now supporting seamless Robinhood Wallet payments. In line with this milestone, investors can now earn up to…
Veeco Announces Date for Second Quarter Financial Results and Conference Call
PLAINVIEW, N.Y., July 16, 2025 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its second quarter 2025 financial results after the market closes on Wednesday, August 6, 2025. The company will host a conference call to review these r…
D-Wave Quantum: Can QBTS Stock Deliver Another 1,000% Gain?
QBTS has witnessed immense growth, skyrocketing over 1,000% in the past twelve months due to increasing enthusiasm for quantum computing.
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
60 Degrees Pharma (SXTP) prices $5M public offering with potential $5M from warrant exercise; funds to support working capital and corporate purposes…….
22x better than Bitcoin… WITHOUT crypto
He calls it “Bitcoin Skimming.” And get this… it's CRUSHING Bitcoin's returns. It's already beaten Bitcoin's returns 6-to-1, 9-to-1, and even 22-to-1. For every $1,000 you made with Bitcoin… you could have made as much as $22,000 with this strategy. That's why this is such a huge turning point for Bitcoin and for the crypto industry in general.
UNFILTERED MARKET COMMENTARY
Everyone’s got tech and banks on a pedestal after Nvidia and Goldman’s beats, but few are talking about biotechs facing margin squeeze when price wars hit after approvals. Biocon shares surge 3% as subsidiary obtains USFDA approval for Kirsty™, a rapid-acting insulin biosimilar (The Times of India), but interchangeable insulin will trigger aggressive discounting that could crush margins across the sector. That’s the silent tremor lurking behind those celebratory stock pops.
Chainlink price forecast amid US asset tokenization push with Blockchain Association partnership (Coinjournal.net) and JPMorgan Chase Set To Explore Stablecoins, Says CEO Jamie Dimon (Bitcoinist) aren’t just isolated experiments—they signal the same tectonic shift: traditional finance and web3 are converging on secure tokenized assets. It’s a strategic pivot that could rewrite custody models and revenue streams across the board.
If you’re hunting returns beyond the usual suspects, think broader: small bets on biotech names with upcoming FDA verdicts and a tokenization play via Chainlink partnerships, while keeping a wary eye on political shocks like Trump’s rumored move against Powell. Manage your risk, but don’t snooze on these catalysts.